Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Next Generation Sequencing of Embryos for Testing the Efficacy of Advanced Sperm Selection Techniques in Males With High Teratozoospermia Index

NCT06231589 is registered in ClinicalTrials.gov with Ganin Fertility Center as lead sponsor.

NCT NCT06231589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06231589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Next Generation Sequencing of Embryos for Testing the Efficacy of Advanced Sperm Selection Techniques in Males With High Teratozoospermia Index
Lead sponsor
Ganin Fertility Center
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2023
Completion date
September 1, 2023
Enrollment
264 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, sperm dna fragmentation, teratozoospermia